新冠肺炎后加快湖北省中成药产业发展的策略  

Strategy For Boosting Chinese Patent Medicine Industry In Hubei Province After COVID-19

作　　者：章程鹏[1] 吕文亮[1] 刘大会[1] 吴和珍[1] 孙易娜[1] 周姝含 ZHANG Cheng-peng;LWen-liang;Liu Da-hui;WU He-zhen;SUN Yi-na;ZHOU Shu-han(Hubei University of Chinese Medcine Wuhan,Hubei,430065,China)

机构地区：[1]湖北中医药大学,湖北武汉430065

出　　处：《时珍国医国药》2020年第2期436-438,共3页Lishizhen Medicine and Materia Medica Research

基　　金：中国工程院院地合作项目(5)。

摘　　要：新冠肺炎疫情将对中国经济社会的发展造成深远影响,在疫情防控中发挥重大作用的中医药相关产业无疑将得到各界重视。顶层设计,长远布局中医药产业发展是当务之急。中医药产业体系庞大,涉及全产业链,中成药工业是整个体系中的枢纽部分,着力提升中成药产业或许是发展湖北省中医药产业的牛鼻子。发展中成药产业需要注重遵循中医理论,做好原始创新,融合多学科力量,增加经费投入,促进中成药制药技术革新,以大品种为引领带动湖北省中医药产业又快又好地发展。COVID-19 will pose profound impact to our national economical and social development.TCM relevant industries in successfully preventing and controlling this pandemic has drawn wide concern.Long-term top level design for TCM industry development should be given top priority.The huge TCM industrial system invloves the whole industry chain.The Chinese patent medicine industry is the hinge part of the whole system.Effects in promoting the Chinese patent medicine industry may probably ring the bull of the TCM industry of Hubei province.Developing the Chinese patent medicine industry should be conducted under TCM theory,together with original innovation,discipline integration and increasing funding that facilitating Chinese patent medi-cine pharmaceutical technology innovation.A rapid and benign development of TCM industry of Hubei province may be realized by mega brand.

关 键 词：中成药产业 创新发展 大品种 新冠肺炎 大健康 

分 类 号：R286[医药卫生—中药学]